These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 25120775

  • 1. Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway.
    Zhu LB, Jiang J, Zhu XP, Wang TF, Chen XY, Luo QF, Shu Y, Liu ZL, Huang SH.
    Int J Clin Exp Pathol; 2014; 7(7):3984-91. PubMed ID: 25120775
    [Abstract] [Full Text] [Related]

  • 2. SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway.
    Chen L, Pei H, Lu SJ, Liu ZJ, Yan L, Zhao XM, Hu B, Lu HG.
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):609-615. PubMed ID: 29461588
    [Abstract] [Full Text] [Related]

  • 3. Bisdemethoxycurcumin suppresses human osteosarcoma U‑2 OS cell migration and invasion via affecting the PI3K/Akt/NF‑κB, PI3K/Akt/GSK3β and MAPK signaling pathways in vitro.
    Ma YS, Peng SF, Wu RS, Chueh FS, Huang WW, Chen PY, Kuo CL, Huang AC, Liao CL, Hsia TC.
    Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36222295
    [Abstract] [Full Text] [Related]

  • 4. Potential Molecular Mechanisms of AURKB in the Oncogenesis and Progression of Osteosarcoma Cells: A Label-Free Quantitative Proteomics Analysis.
    Pi WS, Cao ZY, Liu JM, Peng AF, Chen WZ, Chen JW, Huang SH, Liu ZL.
    Technol Cancer Res Treat; 2018 Dec; 18():1533033819853262. PubMed ID: 31122179
    [Abstract] [Full Text] [Related]

  • 5. BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
    Li YJ, Dong BK, Fan M, Jiang WX.
    Int J Clin Exp Pathol; 2015 Dec; 8(10):12410-8. PubMed ID: 26722427
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of Aurora-B alters osteosarcoma cell malignant phenotype via decreasing phosphorylation of VCP and NF-κB signaling.
    He JY, Xi WH, Zhu LB, Long XH, Chen XY, Liu JM, Luo QF, Zhu XP, Liu ZL.
    Tumour Biol; 2015 May; 36(5):3895-902. PubMed ID: 25874486
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
    Wang TF, Wang H, Peng AF, Luo QF, Liu ZL, Zhou RP, Gao S, Zhou Y, Chen WZ.
    Biochem Biophys Res Commun; 2013 Oct 18; 440(2):229-34. PubMed ID: 24041695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway.
    Jiang C, Ma S, Hu R, Wang X, Li M, Tian F, Jiang W, Zhu L, Bian Z.
    Cell Physiol Biochem; 2018 Oct 18; 46(6):2250-2260. PubMed ID: 29734183
    [Abstract] [Full Text] [Related]

  • 13. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-κB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells.
    Li C, Gao H, Feng X, Bi C, Zhang J, Yin J.
    J Biochem Mol Toxicol; 2020 Dec 18; 34(12):e22597. PubMed ID: 32762018
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB, Tang B, Wang GZ, Xie R, Hu CJ, Wang SM, Wu YY, Liu E, Xie X, Yang SM.
    Cancer Lett; 2015 May 28; 361(1):57-66. PubMed ID: 25727320
    [Abstract] [Full Text] [Related]

  • 15. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
    Zhou Y, Zhu LB, Peng AF, Wang TF, Long XH, Gao S, Zhou RP, Liu ZL.
    Mol Med Rep; 2015 Feb 28; 11(2):1352-7. PubMed ID: 25351625
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z, Zhao J, Yang Y.
    Mol Med Rep; 2018 May 28; 17(5):7313-7318. PubMed ID: 29568965
    [Abstract] [Full Text] [Related]

  • 17. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
    Long XH, Zhang GM, Peng AF, Luo QF, Zhang L, Wen HC, Zhou RP, Gao S, Zhou Y, Liu ZL.
    Oncol Rep; 2014 Jan 28; 31(1):328-34. PubMed ID: 24172910
    [Abstract] [Full Text] [Related]

  • 18. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
    Huang H, Lu Q, Yuan X, Zhang P, Ye C, Wei M, Yang C, Zhang L, Huang Y, Luo X, Luo J.
    Chem Biol Interact; 2022 Sep 25; 365():110068. PubMed ID: 35917943
    [Abstract] [Full Text] [Related]

  • 19. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
    Zheng W, Li S, Huang J, Dong Y, Zhang H, Zheng J.
    Biol Pharm Bull; 2022 Sep 25; 45(9):1283-1290. PubMed ID: 36047196
    [Abstract] [Full Text] [Related]

  • 20. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
    Qu Q, He Z, Jiang Y, Lu D, Long X, Ding Y, Xu B, He X.
    Med Sci Monit; 2019 Oct 07; 25():7527-7537. PubMed ID: 31589596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.